Truist Securities Reiterates Buy Rating on Solid Biosciences (SLDB): "we are buyers of the selloff"

March 12, 2026 8:41 AM

Truist Securities analyst Joon Lee reiterated a Buy rating and $16.00 price target on Solid Biosciences (NASDAQ: SLDB)The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found